Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
作者信息
Peacock M, Heyburn P J, Aaron J E
出版信息
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:231s-237s. doi: 10.1111/j.1365-2265.1977.tb03387.x.
Abstract
Ten patients with vitamin D resistant hypophosphataemic osteomalacia are described. They had hypophosphataemia with a decreased tubular reabsorption of phosphate, malabsorption of calcium and phosphorus, proximal myopathy and extensive osteomalacic changes on iliac crest bone biopsy. The plasma alkaline phosphatase and urine hydroxyproline, however, were raised in only some of the patients. Treatment with 1alpha-hydroxyvitamin D3 in high doses rapidly cured the myopathy, increased calcium and phosphorus absorption and retention and healed the osteomalacia. Phosphorus supplements were not required.
摘要
相似文献
1
Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:231s-237s. doi: 10.1111/j.1365-2265.1977.tb03387.x.
2
1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:239s-244s. doi: 10.1111/j.1365-2265.1977.tb03388.x.
3
Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
Calcif Tissue Res. 1977 May;22 Suppl:55-62. doi: 10.1007/BF02064041.
4
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.评估1,25-二羟维生素D3在X连锁低磷性佝偻病和骨软化症的发病机制及治疗中的作用。
J Clin Invest. 1980 Nov;66(5):1020-32. doi: 10.1172/JCI109930.
5
[A case of adult onset hypophosphatemic vitamin D resistant osteomalacia].[一例成人起病的低磷性维生素D抵抗性骨软化症病例]
Ryumachi. 1992 Oct;32(5):461-7; discussion 466-7.
6
The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia.
Adv Exp Med Biol. 1977;81:431-40. doi: 10.1007/978-1-4613-4217-5_44.
7
Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.线状皮脂腺痣综合征中的低磷性佝偻病/骨软化症：肿瘤诱导性骨软化症的一种变体
J Pediatr. 1986 Dec;109(6):994-1000. doi: 10.1016/s0022-3476(86)80283-9.
8
Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3.常染色体性低磷性骨病对1,25 -（OH）2D3有反应。
Arch Dis Child. 1981 Mar;56(3):203-7. doi: 10.1136/adc.56.3.203.
9
Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.X连锁低磷性佝偻病/骨软化症中骨病的治疗。磷和骨化三醇的诱导与维持治疗。
J Clin Invest. 1985 Jun;75(6):1858-68. doi: 10.1172/JCI111900.
10
Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.儿童期大剂量1α-羟基维生素D3治疗低磷性维生素D抵抗性佝偻病
Arch Dis Child. 1980 Jan;55(1):49-53. doi: 10.1136/adc.55.1.49.
引用本文的文献
1
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.在首个治疗成人X连锁低磷血症的多次递增剂量试验中，人源单克隆抗FGF23抗体（KRN23）的药代动力学和药效学研究
J Clin Pharmacol. 2016 Feb;56(2):176-85. doi: 10.1002/jcph.570. Epub 2015 Aug 11.
2
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.评估1,25-二羟维生素D3在X连锁低磷性佝偻病和骨软化症的发病机制及治疗中的作用。
J Clin Invest. 1980 Nov;66(5):1020-32. doi: 10.1172/JCI109930.
Zotero 插件